23.20
+0.80
+(3.57%)
At close: January 31 at 9:34:14 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-149,677.00
-115,224.00
-87,175.00
-55,779.00
55,463.00
Investing Cash Flow
-417,393.00
-158,456.00
-33,404.00
-69,666.00
-146,243.00
Financing Cash Flow
815,692.00
362,717.00
97,165.00
145,454.00
128,750.00
End Cash Position
401,194.00
157,775.00
68,738.00
92,152.00
72,143.00
Income Tax Paid Supplemental Data
--
--
--
4.00
1.00
Interest Paid Supplemental Data
57.00
69.00
60.00
71.00
82.00
Capital Expenditure
-3,593.00
-2,368.00
-3,443.00
-2,644.00
-493.00
Issuance of Capital Stock
824,234.00
351,945.00
94,962.00
143,253.00
127,234.00
Free Cash Flow
-153,270.00
-117,592.00
-90,618.00
-58,423.00
54,970.00
12/31/2020 - 6/12/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SER Serina Therapeutics, Inc.
4.7000
+2.17%
AADI Aadi Bioscience, Inc.
2.8800
0.00%
CELC Celcuity Inc.
11.95
+1.96%
THTX Theratechnologies Inc.
1.4400
+0.70%
APGE Apogee Therapeutics, Inc.
41.36
-2.68%
VRDN Viridian Therapeutics, Inc.
19.38
-3.49%
ADCT ADC Therapeutics SA
1.6800
-2.33%
CRNX Crinetics Pharmaceuticals, Inc.
40.30
+0.10%
OVID Ovid Therapeutics Inc.
0.6634
-5.24%
COGT Cogent Biosciences, Inc.
9.31
-3.22%